Substance Use Disorders News

The initiation of medications for alcohol use disorder, or AUD, at discharge reduced the incidence of several outcomes like hospital readmissions and ED visits, a study showed.

A systematic review of hundreds of studies showed that medication has the best chance to improve ADHD outcomes in children and that other treatments have varied effects, according to results published in Pediatrics.

While psychedelic use may be associated with fewer psychotic symptoms among adolescents, the link between psychedelics and manic symptoms appears to be associated with genetic vulnerability to schizophrenia or bipolar disorder, data show.

Less than half of pediatricians in the United States who responded to a survey said they felt prepared to counsel patients on opioid use disorder, researchers reported.

More than 1 in 10 high school seniors in the United States reported using delta-8 THC in the past year, according to survey results published in JAMA.

Medicare recipients with various cancer types had more frequent surgical complications when they also had at least one behavioral health disorder, according to study results published in Journal of the American College of Surgeons.

The Substance Abuse and Mental Health Services Administration issued a final rule that permanently allows patients to be prescribed buprenorphine via telehealth, the U.S. Department of Health and Human Services announced in a press release.

A recently released report from the CDC revealed a grim milestone in mental health — a record-breaking 50,000 suicides in 2022.

Patients with opioid use disorder, or OUD, who were treated with buprenorphine during an ED visit had greater odds of continued treatment engagement 30 days later, a study in JAMA Network Open showed.

A Houston-based neurohealth company has received a patent for its non-invasive, frequency-based deep brain stimulation device to address a range of psychiatric and neurologic conditions.